Meta Medikal
Occlutech PFO Occluder​

Occlutech PFO Occluder​

procedural success rate.

efficient closure rate after six months.

force free angulation during release.

Product features

• The Occlutech PFO Occluder has conformable Nitinol braiding with a biocompatible titanium oxide surface.¹⁵
• Optimized braiding: no hub on the left atrial disc to facilitate endothelization.^{21, 22}
• Biocompatible Polyethylenterephthalat (PET) patch allows immediate verification of the occlusion effect by ultrasound and X-ray.
• The ball connection allows up to a 50 degree angle which is intended to reduce tension on the septum, and allow septal alignment prior to release.^{13, 14, 22}

Clinical benefits

• PFO closure using the Occlutech PFO Occluder reduces recurrent stroke ascribed to PFO.^1-3 This reduction was proven successfully in retrospective and prospective clinical trials.^17-19
• Mean procedure time: less than 30 minutes with reduced (P = 0.47) mean fluoroscopic time less than 4.4 mins.¹
• The Occlutech PFO Occluder shows procedural success rate of 99% with efficient closure in 95.5% after six months.^{1, 20}

Products are not approved or available in all geographies. Please check with your Occlutech representative for complete information.